Tau deletion promotes brain insulin resistance
暂无分享,去创建一个
L. Buée | D. Vieau | P. Amouyel | S. Lancel | B. Grenier‐Boley | D. Balschun | T. Issad | P. Pagésy | E. Gerhardt | D. Blum | B. Staels | T. Outeiro | A. Tailleux | J. Dumont | C. Bournonville | M. Hamdane | Emilie Caron | T. Ahmed | S. Eddarkaoui | D. Demeyer | E. Faivre | E. Vallez | K. Bantubungi | S. Humez | A. Leboucher | Elodie Marciniak | Margaux Vileno | P. Pagesy | Emmanuelle Vallez
[1] H. Okano,et al. Correlation of insulin resistance and motor function in spinal and bulbar muscular atrophy , 2017, Journal of Neurology.
[2] B. Bastide,et al. Reorganization of motor cortex and impairment of motor performance induced by hindlimb unloading are partially reversed by cortical IGF-1 administration , 2017, Behavioural Brain Research.
[3] G. Forte,et al. Tau Isoforms Imbalance Impairs the Axonal Transport of the Amyloid Precursor Protein in Human Neurons , 2017, Journal of Neuroscience.
[4] D. Holtzman,et al. The Effects of Peripheral and Central High Insulin on Brain Insulin Signaling and Amyloid-β in Young and Old APP/PS1 Mice , 2016, The Journal of Neuroscience.
[5] D. Holtzman,et al. Changes in insulin and insulin signaling in Alzheimer’s disease: cause or consequence? , 2016, The Journal of experimental medicine.
[6] E. Rimm,et al. A genome‐wide investigation of food addiction , 2016, Obesity.
[7] L. Tan,et al. Peripheral Blood Adipokines and Insulin Levels in Patients with Alzheimer's Disease: A Replication Study and Meta-Analysis. , 2016, Current Alzheimer research.
[8] L. Buée,et al. Tau Protein Quantification in Human Cerebrospinal Fluid by Targeted Mass Spectrometry at High Sequence Coverage Provides Insights into Its Primary Structure Heterogeneity. , 2016, Journal of proteome research.
[9] M. Serrano,et al. PTEN recruitment controls synaptic and cognitive function in Alzheimer's models , 2016, Nature Neuroscience.
[10] J. Attems,et al. The Microtubule-Associated Protein Tau and Its Relevance for Pancreatic Beta Cells , 2015, Journal of diabetes research.
[11] E. Mandelkow,et al. Tau in physiology and pathology , 2015, Nature Reviews Neuroscience.
[12] C. Iadecola,et al. Metabolic and Non-Cognitive Manifestations of Alzheimer's Disease: The Hypothalamus as Both Culprit and Target of Pathology. , 2015, Cell metabolism.
[13] C. Benedict,et al. A Key Role of Insulin Receptors in Memory , 2015, Diabetes.
[14] D. Mott,et al. Hippocampal Insulin Resistance Impairs Spatial Learning and Synaptic Plasticity , 2015, Diabetes.
[15] R. D'Hooge,et al. Rescue of impaired late–phase long-term depression in a tau transgenic mouse model , 2015, Neurobiology of Aging.
[16] D. Munoz,et al. Alzheimer-associated Aβ oligomers impact the central nervous system to induce peripheral metabolic deregulation , 2015, EMBO molecular medicine.
[17] S. Monte. Type 3 diabetes is sporadic Alzheimer׳s disease: Mini-review , 2014, European Neuropsychopharmacology.
[18] G. Braus,et al. Systematic Comparison of the Effects of Alpha-synuclein Mutations on Its Oligomerization and Aggregation , 2014, PLoS genetics.
[19] J. Trojanowski,et al. Abnormal serine phosphorylation of insulin receptor substrate 1 is associated with tau pathology in Alzheimer’s disease and tauopathies , 2014, Acta Neuropathologica.
[20] E. Teng,et al. Loss of MAP Function Leads to Hippocampal Synapse Loss and Deficits in the Morris Water Maze with Aging , 2014, The Journal of Neuroscience.
[21] Mark I. McCarthy,et al. A Central Role for GRB10 in Regulation of Islet Function in Man , 2014, PLoS genetics.
[22] L. Buée,et al. A major role for Tau in neuronal DNA and RNA protection in vivo under physiological and hyperthermic conditions , 2014, Front. Cell. Neurosci..
[23] G. Collingridge,et al. Microtubule-associated protein tau is essential for long-term depression in the hippocampus , 2014, Philosophical Transactions of the Royal Society B: Biological Sciences.
[24] Mathias Jucker,et al. Self-propagation of pathogenic protein aggregates in neurodegenerative diseases , 2013, Nature.
[25] P. Aisen,et al. Individuals with Alzheimer's disease exhibit a high prevalence of undiagnosed impaired glucose tolerance and type 2 diabetes mellitus , 2013, Alzheimer's & Dementia.
[26] Meaghan Morris,et al. Age-appropriate cognition and subtle dopamine-independent motor deficits in aged Tau knockout mice , 2013, Neurobiology of Aging.
[27] Jeffrey N. Browndyke,et al. Phenotypic regional functional imaging patterns during memory encoding in mild cognitive impairment and Alzheimer's disease , 2013, Alzheimer's & Dementia.
[28] M. Serrano,et al. PTEN in cancer, metabolism, and aging , 2013, Trends in Endocrinology & Metabolism.
[29] L. Buée,et al. NMDA receptor dysfunction contributes to impaired brain‐derived neurotrophic factor‐induced facilitation of hippocampal synaptic transmission in a Tau transgenic model , 2013, Aging cell.
[30] S. Hébert,et al. Deregulation of Protein Phosphatase 2A and Hyperphosphorylation of τ Protein Following Onset of Diabetes in NOD Mice , 2013, Diabetes.
[31] F. D. De Felice. Alzheimer's disease and insulin resistance: translating basic science into clinical applications. , 2013, The Journal of clinical investigation.
[32] M. White,et al. Regulation of insulin sensitivity by serine/threonine phosphorylation of insulin receptor substrate proteins IRS1 and IRS2 , 2012, Diabetologia.
[33] T. Issad,et al. Effect of Insulin Analogues on Insulin/IGF1 Hybrid Receptors: Increased Activation by Glargine but Not by Its Metabolites M1 and M2 , 2012, PloS one.
[34] Allissa Dillman,et al. MAPT expression and splicing is differentially regulated by brain region: relation to genotype and implication for tauopathies , 2012, Human molecular genetics.
[35] J. Schneider,et al. Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. , 2012, The Journal of clinical investigation.
[36] D. Munoz,et al. An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer's disease- associated Aβ oligomers. , 2012, The Journal of clinical investigation.
[37] I. Torres-Aleman,et al. The many faces of insulin-like peptide signalling in the brain , 2012, Nature Reviews Neuroscience.
[38] Blaine R. Roberts,et al. Tau deficiency induces parkinsonism with dementia by impairing APP-mediated iron export , 2012, Nature Medicine.
[39] B. Coupé,et al. Postnatal Growth after Intrauterine Growth Restriction Alters Central Leptin Signal and Energy Homeostasis , 2012, PloS one.
[40] Gloria Lee,et al. Tau and tauopathies. , 2012, Progress in molecular biology and translational science.
[41] Dietmar R. Thal,et al. Stages of the Pathologic Process in Alzheimer Disease: Age Categories From 1 to 100 Years , 2011, Journal of neuropathology and experimental neurology.
[42] Ying Liu,et al. Deficient brain insulin signalling pathway in Alzheimer's disease and diabetes , 2011, The Journal of pathology.
[43] Meaghan Morris,et al. The Many Faces of Tau , 2011, Neuron.
[44] R. Mayeux,et al. Epidemiology of Alzheimer disease , 2011, Nature Reviews Neurology.
[45] L. Buée,et al. Nuclear Tau, a Key Player in Neuronal DNA Protection* , 2010, The Journal of Biological Chemistry.
[46] T. Outeiro,et al. Zooming into protein oligomerization in neurodegeneration using BiFC. , 2010, Trends in biochemical sciences.
[47] Jürgen Götz,et al. Dendritic Function of Tau Mediates Amyloid-β Toxicity in Alzheimer's Disease Mouse Models , 2010, Cell.
[48] Mark A. Smith,et al. Faculty Opinions recommendation of Diabetes-accelerated memory dysfunction via cerebrovascular inflammation and Abeta deposition in an Alzheimer mouse model with diabetes. , 2010 .
[49] J. Attems,et al. Expression of TAU in insulin-secreting cells and its interaction with the calcium-binding protein secretagogin. , 2010, The Journal of endocrinology.
[50] Ryuichi Morishita,et al. Diabetes-accelerated memory dysfunction via cerebrovascular inflammation and Aβ deposition in an Alzheimer mouse model with diabetes , 2010, Proceedings of the National Academy of Sciences.
[51] Jong Jin Kim,et al. The distribution and most recent common ancestor of the 17q21 inversion in humans. , 2010, American journal of human genetics.
[52] Alex Doney,et al. Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge , 2010, Nature Genetics.
[53] Rosemary O’Connor,et al. Defects in IGF-1 receptor, insulin receptor and IRS-1/2 in Alzheimer's disease indicate possible resistance to IGF-1 and insulin signalling , 2010, Neurobiology of Aging.
[54] Christian Gieger,et al. New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk , 2010, Nature Genetics.
[55] H. Vinters,et al. β-Amyloid Oligomers Induce Phosphorylation of Tau and Inactivation of Insulin Receptor Substrate via c-Jun N-Terminal Kinase Signaling: Suppression by Omega-3 Fatty Acids and Curcumin , 2009, The Journal of Neuroscience.
[56] M. Zvelebil,et al. Phosphorylation Regulates Tau Interactions with Src Homology 3 Domains of Phosphatidylinositol 3-Kinase, Phospholipase Cγ1, Grb2, and Src Family Kinases* , 2008, Journal of Biological Chemistry.
[57] Bradley T. Hyman,et al. Formation of Toxic Oligomeric α-Synuclein Species in Living Cells , 2008, PloS one.
[58] A. Delacourte,et al. Biochemistry of Tau in Alzheimer’s disease and related neurological disorders , 2008, Expert review of proteomics.
[59] Ram Dixit,et al. Differential Regulation of Dynein and Kinesin Motor Proteins by Tau , 2008, Science.
[60] P. Mehta,et al. Intranasal insulin improves cognition and modulates β-amyloid in early AD , 2008, Neurology.
[61] W. Klein,et al. Amyloid beta oligomers induce impairment of neuronal insulin receptors , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[62] M. Reger,et al. Intranasal insulin improves cognition and modulates beta-amyloid in early AD. , 2008, Neurology.
[63] C. Grillo,et al. Lentivirus-mediated downregulation of hypothalamic insulin receptor expression , 2007, Physiology & Behavior.
[64] S. Woods,et al. Intraventricular insulin and leptin reduce food intake and body weight in C57BL/6J mice , 2006, Physiology & Behavior.
[65] J. Trojanowski,et al. Pathological tau: a loss of normal function or a gain in toxicity? , 2005, Nature Neuroscience.
[66] A. Artola,et al. Insulin modulates hippocampal activity‐dependent synaptic plasticity in a N‐methyl‐d‐aspartate receptor and phosphatidyl‐inositol‐3‐kinase‐dependent manner , 2005, Journal of neurochemistry.
[67] A. Delacourte,et al. p25/Cdk5-mediated retinoblastoma phosphorylation is an early event in neuronal cell death , 2005, Journal of Cell Science.
[68] Ronald C Petersen,et al. Increased risk of type 2 diabetes in Alzheimer disease. , 2004, Diabetes.
[69] L. Michalik,et al. In situ localization with digoxigenin-labelled probes of tau-related mRNAs in the rat pancreas , 1995, The Histochemical Journal.
[70] Zhaohui Feng,et al. Decreasing hypothalamic insulin receptors causes hyperphagia and insulin resistance in rats , 2002, Nature Neuroscience.
[71] Y. Barde,et al. Neurotrophins are required for nerve growth during development , 2001, Nature Neuroscience.
[72] R. Klein,et al. Role of brain insulin receptor in control of body weight and reproduction. , 2006, Science.
[73] H. Buschke,et al. Memory and mental status correlates of modified Braak staging , 1999, Neurobiology of Aging.
[74] George Paxinos,et al. The Mouse Brain in Stereotaxic Coordinates , 2001 .
[75] C. Duyckaerts,et al. Modeling the Relation Between Neurofibrillary Tangles and Intellectual Status , 1997, Neurobiology of Aging.
[76] E. Van Obberghen,et al. Phosphorylation of Insulin Receptor Substrate-1 on Multiple Serine Residues, 612, 632, 662, and 731, Modulates Insulin Action (*) , 1996, The Journal of Biological Chemistry.
[77] P. Davies,et al. Mitotic mechanisms in Alzheimer's disease? , 1996, The Journal of cell biology.
[78] T. Issad,et al. Isoproterenol inhibits insulin-stimulated tyrosine phosphorylation of the insulin receptor without increasing its serine/threonine phosphorylation. , 1995, European journal of biochemistry.
[79] G. Wilcock,et al. Hyperinsulinaemia and Alzheimer's disease. , 1994, Age and ageing.
[80] N. Hirokawa,et al. Altered microtubule organization in small-calibre axons of mice lacking tau protein , 1994, Nature.
[81] G. Meneilly,et al. Alterations in Glucose Metabolism in Patients with Alzheimer's Disease , 1993, Journal of the American Geriatrics Society.
[82] S. Craft,et al. Glucose and memory in mild senile dementia of the Alzheimer type. , 1992, Journal of clinical and experimental neuropsychology.
[83] R. Martins,et al. Neuronal origin of a cerebral amyloid: neurofibrillary tangles of Alzheimer's disease contain the same protein as the amyloid of plaque cores and blood vessels. , 1985, The EMBO journal.
[84] S. Woods,et al. Chronic intracerebroventricular infusion of insulin reduces food intake and body weight of baboons , 1979, Nature.